From theory to practice: the versatility of drug-coated balloons around the world
<p class="moderator speaker-name">Anchorperson: <span classs="personname">Pedro Lemos</span></p><p class="moderator speaker-name">Spokesperson: <span classs="personname">Bruno Scheller</span></p><p class="moderator speaker-name">Discussants: <span classs="personname">Victor Alfonso Jimenez Diaz, Antoinette Neylon</span></p>
Watch this session if you want
<ul> <li>To learn more about the safety and effectiveness of the best-investigated coronary drug-coated balloons</li> <li>To learn how drug-coated balloons are used in a variety of settings around the world</li> <li>To gain confidence in using drug-coated balloon with a data-driven treatment choice</li> <li>To gain an understanding how drug-coated balloon can reduce complexity in today’s PCI</li> <li>To gain an understanding of the active drug-coated balloon coatings paclitaxel and sirolimus and their strength in various indications</li> <li>To receive the latest clinical insights into the available data for drug-coated balloon usage in de-novo lesions</li> <li>To learn about practical experiences on drug-coated balloon in large vessels, bifurcations, multivessel disease and CTO</li> <li>To get an understanding how to use the hybrid approach especially for challenging lesions to improve clinical outcome</li> </ul>
<div class="intervention"><div class="interventionTitle">Welcome and session objectives</div><p class="speaker-intervention-name-img">Pedro Lemos</p></div><div class="intervention"><div class="interventionTitle">Where it all started – A journey to the origin of drug-coated balloon in Europe</div><p class="speaker-intervention-name-img">Bruno Scheller</p></div><div class="intervention"><div class="interventionTitle">Pave the way in calcified lesions – Synergistic use of drug-coated balloon and intravascular lithotripsy</div><p class="speaker-intervention-name-img">Pedro Lemos</p></div><div class="intervention"><div class="interventionTitle">Metall-free PCI in STEMI - Go or no go?</div><p class="speaker-intervention-name-img">Antoinette Neylon</p></div><div class="intervention"><div class="interventionTitle">Deciphering sirolimus efficacy - An OCT approach to understand clinical device performance</div><p class="speaker-intervention-name-img">Victor Alfonso Jimenez Diaz</p></div><div class="intervention"><div class="interventionTitle">The journey continues – From paclitaxel to sirolimus?</div><p class="speaker-intervention-name-img">Bruno Scheller</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div></div><div class="intervention"><div class="interventionTitle">Session evaluation and key learnings</div><p class="speaker-intervention-name-img">Bruno Scheller</p></div>
